ProKidney (MEX:PROK) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ProKidney's Free Cash Flow for the three months ended in Mar. 2024 was MXN-590.93 Mil. ProKidney's Revenue for the three months ended in Mar. 2024 was MXN0.00 Mil. Therefore, ProKidney's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, ProKidney's current FCF Yield % is -43.63%.

The historical rank and industry rank for ProKidney's FCF Margin % or its related term are showing as below:

MEX:PROK's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -137.43
* Ranked among companies with meaningful FCF Margin % only.

ProKidney FCF Margin % Historical Data

The historical data trend for ProKidney's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney FCF Margin % Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of ProKidney's FCF Margin %

For the Biotechnology subindustry, ProKidney's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProKidney's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProKidney's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ProKidney's FCF Margin % falls into.

ProKidney FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ProKidney's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2109.322	/	0
	=	%

ProKidney's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-590.926	/	0
	=	%

ProKidney FCF Margin % Related Terms

Thank you for viewing the detailed overview of ProKidney's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney (MEX:PROK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.